Monthly Archives: December 2016

Paxman Seeks FDA Clearance For Advanced Scalp Cooling Technology

Medilink member Paxman has announced that it has filed a 510(k) application with the Food and Drug Administration to market an advanced scalp cooling technology for the prevention of hair loss in women undergoing certain forms of chemotherapy for breast cancer. The pioneering Paxman Scalp Cooling System device, developed in the UK, has been shown…
Read more

Arquer Diagnostics Appoints Nadia Whittley as CEO

Sunderland based Arquer Diagnostics Ltd   , a diagnostic company which has developed a high sensitivity, high specificity, ELISA-based urine test for cancer, announced that it has appointed Nadia Whittley as CEO. With significant experience in strategy, sales and marketing, organisational effectiveness, M&A and fundraising in the small and mid-cap sectors, Nadia’s focus at Arquer will…
Read more

Top Health Award for South Tyneside Team

The Gastroenterology team at the South Tyneside Foundation Trust has been recognised in the HSJ Awards 2016 as the best in the country for their impact on clinical research. HSJ Awards 2016 They demonstrated how they had targeted research to improve the quality of care, benefit patients and drive innovation and had a global impact.…
Read more

QuantuMDx receives grant funding from Gates Foundation for diagnostic to reach the missing 4.3 million TB cases a year

Newcastle upon Tyne, QuantuMDx has announced that it has received funding from the Bill & Melinda Gates Foundation to further develop and test its CAPTURE-XT™ pathogen concentration technology and Q-POC™ molecular diagnostic (MDx) platform for rapid low cost TB detection and drug susceptibility testing (DST) in response to World Health Organisation target product profiles. The…
Read more